Article
Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
Journal of the National Cancer Institute - 1 Mar 2000
Xie D, Shu X O, Deng Z, Wen W Q, Creek K E, Dai Q, Gao Y T, Jin F, Zheng W
Abstract excerpt
BACKGROUND: Alterations of the HER2 (also known as erbB-2 or neu) proto-oncogene have been implicated in the carcinogenesis and prognosis of breast cancer. A polymorphism at codon 655 (GTC/valine to ATC /isoleucine [Val(655)Ile]) in the transmembrane domain-coding region of this gene has been identified and may be associated with the risk of breast cancer. We evaluated this hypothesis in a subgroup of women who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
